Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Capital Expenditures (2020 - 2026)

RxSight filings provide 6 years of Capital Expenditures readings, the most recent being $1.1 million for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 77.47% to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.8 million, a 29.6% decrease, with the full-year FY2025 number at $3.8 million, down 29.6% from a year prior.
  • Capital Expenditures hit $1.1 million in Q4 2025 for RxSight, up from $581000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $5.0 million in Q4 2024 to a low of -$2.4 million in Q3 2023.
  • Median Capital Expenditures over the past 5 years was $434000.0 (2021), compared with a mean of $694250.0.
  • Biggest five-year swings in Capital Expenditures: plummeted 2196.77% in 2022 and later soared 7008.45% in 2024.
  • RxSight's Capital Expenditures stood at $1.8 million in 2021, then rose by 24.42% to $2.2 million in 2022, then tumbled by 96.83% to $71000.0 in 2023, then soared by 7008.45% to $5.0 million in 2024, then tumbled by 77.47% to $1.1 million in 2025.
  • The last three reported values for Capital Expenditures were $1.1 million (Q4 2025), $581000.0 (Q3 2025), and $1.9 million (Q2 2025) per Business Quant data.